ClinicalTrials.gg
Not yet recruitingNCT07921563Updated Nov 6, 2026

The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity

An interventional study of Home-based exercise and weight management program in Osteoarthritis of the Knee, sponsored by Dartmouth-Hitchcock Medical Center. Not yet recruiting at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Dartmouth-Hitchcock Medical Center · Not applicable, Interventional, and Supportive care

Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Study summary

Knee Osteoarthritis is one of the most common causes of chronic joint pain. Although clinical guidelines recommend weight loss and regular physical activity as first line treatments this can be difficult for patients to do. This study aims to better understand what makes it harder or easier for patients to participate in weight management or exercise programs and to design a weight and exercise program specifically tailored to older adults managing chronic health issues.

Based on input from patients and providers we will design and pilot a virtual exercise and weight management program to help patients with knee osteoarthritis in their home. Participants will be asked to fill out questionnaires about their knee pain and have phone or video check-ins with the study team to monitor progress.

02

Conditions studied

  • Osteoarthritis of the Knee
03

In context

Osteoarthritis, Knee

3,292 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

This study's planned enrollment of 50 is below the median of 68 across 2,714 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Dartmouth-Hitchcock Medical Center is the lead sponsor of 488 studies on the registry; 71 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 21 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinician-diagnosed osteoarthritis of the knee
  • Obesity ( >30)
  • Cardiovascular disease and/or diabetes mellitus
  • English speaking

Exclusion criteria

Exclusion Criteria:

  • Inflammatory arthritis
  • Antecedent acute trauma
  • Consistent use of a wheelchair
  • Moderate to severe dementia
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Home-based exercise and weight management program

    The foundation of the program will be based on current activity as well as weight guidelines and recommendations; adjustments will be made to maximize facilitators and minimize barriers identified in previous studies.

    Behavioral: Home-based exercise and weight management program

Interventions

  • BehavioralHome-based exercise and weight management program

    This is the only intervention that will be assigned to participants. Program will be based on participant's current activity level and current weight guidelines.

06

What researchers measure

Primary outcomes

  1. Knee Injury and Osteoarthritis Outcomes Score (KOOS)

    A valid, reliable, and responsive scale developed for use in studies of knee problems including osteoarthritis.

    Time frame: 3 and 6 months

  2. Prospective preference assessment

    Descriptive feasibility outcome, a 5 point likert scale used to determine patient willingness to participate in the research.

    Time frame: Baseline

Secondary outcomes

  1. Use, dose, and frequency of analgesics

    Patient-reported counts of the use, dose, and frequency of pain medications used, including non-steroidal anti-inflammatory drugs

    Time frame: 3 and 6 months

  2. Self-reported current weight

    Patients will be asked to self report their current weight at the defined time points

    Time frame: 3 and 6 months

  3. Participant satisfaction and adherence

    Patient satisfaction will be measured using a 5 point Likert scale for a series of questions aimed at perceived effectiveness of the intervention, ease of use and likeliness of continuing in the intervention

    Time frame: 3 and 6 months

  4. The Physical Activity Scale for the Elderly (PASE)

    A recommended and reliable assessment for physical activity in older adults that has demonstrated positive correlation with Actigraph monitor data

    Time frame: 3 and 6 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — The phenotypic data associated with enrolled participants will be shared by depositing these data in the Open Science Framework data repository. Additional data documentation and de-identified IPD including demographics, diagnoses, and outcomes will be deposited. Resources such as study protocols and statistical analyses codes will also be made available.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Outcome data will be deposited into the Open Science Framework repository as soon as possible but no later than within one year of the completion of the funded project period for the parent away or upon acceptance of the data for publication, or public disclosure of a submitted patent application, whichever is earlier. Data will remain available for a period of 5 years.

Access criteria: Data and supporting information will be shared with investigators working in accordance to guidelines set by the data repository. Meta-analysis data and associated phenotypic data, along with data content, format, and organization will be made available to investigators through the Open Science Framework data repository.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07921563
Responsible party
Lindsey.A.MacFarlane (Rheumatologist, Dartmouth-Hitchcock Medical Center) — Principal investigator
First posted
Nov 6, 2026
Start date
May 2027 (estimated)
Primary completion
Nov 2027 (estimated)
Completion
Jan 2029 (estimated)
Last update
Nov 6, 2026

Study contacts

Lindsey A MacFarlane, MD, MPH
Contact
Lindsey.A.MacFarlane@hitchcock.org
(603) 650-8622

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion